Takeda Pharmaceutical’s experimental dengue vaccine has produced promising long-term results in clinical tests, boosting the Japanese company’s global hopes for a product that will take on Sanofi’s Dengvaxia.
Source: U.S.
Takeda Pharmaceutical’s experimental dengue vaccine has produced promising long-term results in clinical tests, boosting the Japanese company’s global hopes for a product that will take on Sanofi’s Dengvaxia.
Source: U.S.